e-learning
resources
ERJ
2015
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Beta-blockers in pulmonary arterial hypertension: evolving concepts of right heart failure
de Man Frances S., Handoko M. Louis
Source:
Eur Respir J 2015; 46: 619-621
Journal Issue:
September
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
de Man Frances S., Handoko M. Louis. Beta-blockers in pulmonary arterial hypertension: evolving concepts of right heart failure. Eur Respir J 2015; 46: 619-621
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on acute decompensated pulmonary hypertension
ERS statement on chronic thromboembolic pulmonary hypertension
COVID-19 and the pulmonary circulation
Related content which might interest you:
Right heart failure in pulmonary hypertension
Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2014
Right heart imaging and failure in pulmonary hypertension
Source: ERS Course 2017 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2017
Prognostic factors in pulmonary arterial hypertension: assessing the course of the disease
Source: Eur Respir Rev 2011; 20: 236-242
Year: 2011
Pulmonary arterial hypertension or left heart disease with pulmonary hypertension? Toward noninvasive clarity, but time for a new paradigm
Source: Eur Respir J 2015; 46: 299-302
Year: 2015
Under pressure: pulmonary hypertension associated with left heart disease
Source: Eur Respir Rev 2015; 24: 665-673
Year: 2015
How to define pulmonary hypertension due to left heart disease
Source: Eur Respir J 2016; 48: 553-555
Year: 2016
Imaging right heart failure in pulmonary hypertension
Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease
Year: 2018
Pulmonary hypertension due to left heart disease
Source: Eur Respir J, 53 (1) 1801897; 10.1183/13993003.01897-2018
Year: 2019
Perspectives on novel therapeutic strategies for right heart failure in pulmonary arterial hypertension: lessons from the left heart
Source: Eur Respir Rev 2009; 19: 72-82
Year: 2010
Targeted proteomics of right heart adaptation to pulmonary arterial hypertension
Source: Eur Respir J, 57 (4) 2002428; 10.1183/13993003.02428-2020
Year: 2021
Inhaled iloprost for patients with pulmonary arterial hypertension and right heart failure
Source: Annual Congress 2010 - Pulmonary circulation I
Year: 2010
Pulmonary hypertension associated with left heart disease
Source: Eur Respir Mon 2012; 57: 119-137
Year: 2012
The association between resting and mild-to-moderate exercise pulmonary artery pressure
Source: Eur Respir J 2012; 39: 313-318
Year: 2012
Association of renal dysfunction with cardiac output and right atrial pressure in pulmonary arterial hypertension
Source: Annual Congress 2011 - Physiology of human pulmonary hypertension
Year: 2011
Differences of right ventricular diastolic stiffness in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Source: International Congress 2019 – Haemodynamics and chronic thromboembolic pulmonary hypertension
Year: 2019
Right heart catheterisation is still a fundamental part of the follow-up assessment of pulmonary arterial hypertension
Source: Eur Respir J, 52 (1) 1800738; 10.1183/13993003.00738-2018
Year: 2018
Is right heart catheterisation still a fundamental part of the follow-up assessment of pulmonary arterial hypertension? The argument against
Source: Eur Respir J, 52 (1) 1800996; 10.1183/13993003.00996-2018
Year: 2018
Plasma big-endothelin and hemodynamics in patients with pulmonary arterial hypertension compared to patients with chronic left heart failure with and without pulmonary venous hypertension
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept